FY20 Earnings Update July 23, 2020 Private & Confidential - PowerPoint PPT Presentation

BLK: Founded in 1959, Collaborated in 2009 NANAVATI: Founded in 1950, Collaborated in 2014 a passion for healing … FY20 – Earnings Update July 23, 2020 Private & Confidential Private & Confidential 1 1

Disclaimer The information in this release has been included in good faith and is meant for general purposes only. Such information is based on the management’s perception of business, market conditions and overall growth potential by the relevant parties. This information is disseminated generally and not addressed to any person or party or for any purpose specific or otherwise. It should not be relied upon for any specific purpose and no representation or warranty is given as regards to its accuracy or completeness. No information in this release shall constitute an invitation to invest in any of the entities referenced in this announcement or their affiliates. None of the parties referenced in this announcement (including their affiliates) nor their officers, employees or agents shall be liable for any loss, damage or expense arising out of any action taken on the basis of this release, including, without limitation, any loss of opportunity, profit, indirect, incidental or consequential loss or any actions undertaken based on information provided in this release. Figures presented may have been regrouped where required for ease of comparison Certain statements in this release are forward-looking statements, which involve a number of risks, uncertainties, assumptions and other factors that could cause actual results to differ materially from those in such forward-looking statements. All statements, other than statements of historical fact are statements that could be deemed forward looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding impact of pending regulatory proceedings, non – completion of conditions agreed between parties to the transaction, approval for the merger not being obtained, ability to recognize the anticipated benefits of the merger including potential growth and business synergies, fluctuations in earnings, dependency on good monsoons and other climatic conditions, fluctuations in foreign currencies ability of each of the relevant parties to manage growth, intense competition in the business any other business and corporate actions. There can be no assurance that the forward looking statements made herein will prove to be accurate, and issuance of such forward looking statements should not be regarded as a direct or indirect, express or implied, representation or warranty of any nature whatsoever by any of the relevant parties, or any other person, that the objective and plans envisaged by the parties hereto will be achieved. All forward looking statements made herein are based on information presently available to the management of the relevant entities set out herein and they do not undertake or are in anyway obliged to update any forward-looking statement that may be made from time to time by or on behalf of each of the entities or the proposed transaction. This presentation should not, nor should anything contained in it, form the basis of, or be relied upon in any connection with any contract or commitment whatsoever. This presentation is not intended to be a prospectus (as defined under the Companies Act, 2013, as amended) or an offer document under the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, as amended. Private & Confidential Private & Confidential 2 2

Contents About the company 4 Financial and Operational Highlights 9 Covid-19: Response and contribution 17 Scheme Update 19 Appendix 23 - Overview of BLK Hospital - Overview of Nanavati Hospital 30 Private & Confidential Private & Confidential 3 3

About the Company Private & Confidential Private & Confidential 4 4

One Of The Fastest Growing Metro Focused Quaternary Care Service Provider  Promoted by Abhay Soi, having in-depth experience in turning around hospitals  Business of developing & operating high-end quaternary care facilities since 2009  Meaningful presence in Delhi & Mumbai, the most attractive healthcare markets in India Background  Long-term collaboration through Operations & Management arrangements with two iconic hospitals: — BLK Hospital, Delhi - 650 beds with ~540 census beds — Nanavati Hospital, Mumbai - 350 beds with ~328 census beds  Backed by KKR, Private equity fund of global repute  Established clinical programs with 50+ clinical programs under one roof CNBC TV 18 Best Multi-speciality Hospital in  Largest & fastest growing Bone Marrow Transplant program outside N. America in a single Focus on Clinical facility Metro Award for BLK in 2018 Excellence  Amongst India’s most comprehensive cancer care programs, both at Delhi and Mumbai  Best Multi-speciality Hospital North Award,  Well established program for cardiac care, bone marrow, heart, kidney and liver transplant 2019- 20, by ET Healthworld  JCI, NABH, NABL accreditations  Trusted Hospital (Delhi & NCR) Award at  India Today Health Summit, 2018 (Readers’ Independent board of directors Strong Digest)  Experienced management team with deep expertise in healthcare Team   AHPI Award for Quality Beyond Leading team of ~1,200 doctors (including visiting consultants) across 2 hospitals Accreditation for three consecutive years -  2017, 2018 and 2019 Track record of value creation — BLK – Revenue CAGR of 37% from FY10 to FY20 and EBITDA CAGR of 46% from FY13 to  AHPI Award for Best Hospital to work for - FY20 respectively Strong Financial 2016 Performance (1) — Nanavati – Revenue CAGR of 19% from FY15 to FY20; FY20 EBITDA of 6.3% compared to  ICWAI award for excellence in cost negative (15%) EBITDA in FY15 prior to assuming operations management – 2017  Well capitalized  Large medical tourism business – Treated over 20,000 international patients post FY15 Note: 1. Revenue and Normalized EBITDA from I-GAAP/ IND AS FS | Does not include corporate overheads Private & Confidential Private & Confidential 5 5

Snapshot Capacity ~1,000 2 Facilities beds ARPOB (1) # of 52k ~ 1,200 (INR/OBD) Physicians IPD & day OPD 1 Lac+ ~5 lacs care Consults Procedures Covid-19 IPD 300+ 70% Beds Occupancy Note: 1. ARPOB is calculated as Gross Revenue / Total OBD | Abovementioned numbers are for the year ended March 31, 2020 | Private & Confidential Private & Confidential 6 6

Consistent Growth to leadership… BLK – Net Revenue (INR Cr.) 701  Revenue grew at a CAGR of ~37% during 604 +37% 448 502 521 FY10 to FY20 from INR 31 Cr to INR 701 Cr 378  Leading healthcare provider in Central Delhi 283 213 125  74 Capacity for expansion by 190 beds 31 FY10 FY11 FY12 FY13 FY14 FY15 FY16 FY17 FY18 FY19 FY20 Nanavati – Net Revenue (INR Cr.)  Revenue grew at a CAGR of 19% from commencement of O&M arrangement in 357 FY15 to INR ~357 Cr in FY20 327 +19% 298  Turnaround of operations from negative 240 (15%) EBITDA to ~6.3% margin in FY20 185 150  Brownfield capacity for expansion by 550+ beds FY15 FY16 FY17 FY18 FY19 FY20 Note: Based on I-GAAP Financials/ MIS. Revenue excludes ‘Other operating income’ Private & Confidential Private & Confidential 7 7